Key facts
- This page summarizes Ryan Pardo's Form 4 filing for LifeStance Health Group, Inc. (LFST).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 13 Nov 2026, 21:05.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
Sale
Additional SEC filing notes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Footnote F1
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $14.285 to $14.7878 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Footnote F2
Represents shares sold pursuant to a plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) that was adopted on August 11, 2026.
Footnote F3
Represents shares sold pursuant to a plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) that was adopted on August 10, 2026.
Footnote F4
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $14.285 to $14.7878 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Footnote F5
Shares held of record by Kimberly Pardo Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities on this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Securities and Exchange Act of 1934 or for any other purpose.
SEC remarks
Chief Legal Officer and Secretary